Stephen Rocamboli - May 26, 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Director
Signature
/s/ Sheldon L. Koenig, by power of attorney
Stock symbol
ESPR
Transactions as of
May 26, 2022
Transactions value $
$0
Form type
4
Date filed
5/27/2022, 04:13 PM
Previous filing
May 17, 2022
Next filing
Dec 30, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ESPR Stock Option (right to buy) Award $0 +40K $0.00 40K May 26, 2022 Common Stock 40K $5.51 Direct F1
transaction ESPR Stock Option (right to buy) Award $0 +1.59K $0.00 1.59K May 26, 2022 Common Stock 1.59K $5.51 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The awards vest over a three (3) year period in equal annual installments, the first of which will be May 26, 2023.
F2 The awards vest in full on the earlier of (i) May 26, 2023 and (ii) the Issuer's next annual meeting of stockholders following May 26, 2022.